Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

View All Documentation

870273C

Avanti

18:1 Biotinyl Cap PE

Avanti Research™ - A Croda Brand 870273C

Synonyme(s) :

1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) (sodium salt)

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C57H102N4O11PNaS
Numéro CAS:
384835-51-2
Poids moléculaire :
1105.47
Code UNSPSC :
12352211
Nomenclature NACRES :
NA.25

Forme

liquid

Conditionnement

pkg of 1 × 2.5 mL (870273C-25mg)
pkg of 2 × 4 mL (870273C-200mg)

Fabricant/nom de marque

Avanti Research™ - A Croda Brand 870273C

Concentration

10 mg/mL (870273C-25mg)
25 mg/mL (870273C-200mg)

Conditions d'expédition

dry ice

Température de stockage

−20°C

Chaîne SMILES 

[H][C@@](COP([O-])(OCCNC(CCCCCNC(CCCC[C@](SC[C@@]1(NC(N2)=O)[H])([C@]12[H])[H])=O)=O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[Na+]

InChI

1S/C57H103N4O11PS.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-33-41-54(64)69-46-49(72-55(65)42-34-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)47-71-73(67,68)70-45-44-59-53(63)39-32-31-37-43-58-52(62)40-36-35-38-51-56-50(48-74-51)60-57(66)61-56;/h17-20,49-51,56H,3-16,21-48H2,1-2H3,(H,58,62)(H,59,63)(H,67,68)(H2,60,61,66);/q;+1/p-1/b19-17-,20-18-;/t49-,50+,51+,56+;/m1./s1

Clé InChI

VQSGNVZURNOPBT-XEAQQBNDSA-M

Description générale

18:1 Biotinyl Cap PE, also known as 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) or DOPE-B-Cap, belongs to a class of head group modified functionalized lipids.

Application

18:1 Biotinyl Cap PE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) has been used in preparation of liposomes and large unilamellar vesicles (LUV).

Conditionnement

5 mL Clear Glass Sealed Ampule (870273C-200mg)
5 mL Clear Glass Sealed Ampule (870273C-25mg)

Informations légales

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Souvent commandé avec ce produit

Réf. du produit
Description
Tarif

Pictogrammes

Skull and crossbonesHealth hazard
GHS06,GHS08

Mention d'avertissement

Danger

Classification des risques

Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 Oral - STOT SE 3

Organes cibles

Central nervous system, Liver,Kidney

Code de la classe de stockage

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Slide 1 of 6

1 of 6

DSPE-PEG(2000) Biotin Avanti Research™ - A Croda Brand 880129C

Avanti

880129C

DSPE-PEG(2000) Biotin

16:0-18:1 PC Avanti Research™ - A Croda Brand

Avanti

850457C

16:0-18:1 PC

18:1 (Δ9-Cis) PE (DOPE) Avanti Research™ - A Croda Brand

Avanti

850725C

18:1 (Δ9-Cis) PE (DOPE)

18:1 PS (DOPS) Avanti Research™ - A Croda Brand

Avanti

840035P

18:1 PS (DOPS)

Syringe (1000 μL) Avanti Research™ - A Croda Brand

Avanti

610017

Syringe (1000 μL)

16:0-18:1 PC Avanti Research™ - A Croda Brand

Avanti

850457P

16:0-18:1 PC

Hideyo Takatsuki et al.
Nanotechnology, 22(24), 245101-245101 (2011-04-22)
The potential of using actin bundles for the transport of liposomes and single cells across myosin-coated surfaces is investigated. Compared to that observed with filamentous actin, the liposome transport using actin bundles was more linear in nature and able to
David K Y Zhang et al.
Nature protocols, 15(3), 773-798 (2020-01-15)
Synthetic antigen-presenting cells (APCs) are used to mediate scalable ex vivo T-cell expansion for adoptive cell therapy. Recently, we developed APC-mimetic scaffolds (APC-ms), which present signals to T cells in a physiological manner to mediate rapid and controlled T-cell expansion.
Yanqi Yu et al.
ACS nano (2018-11-14)
Understanding the binding of nanoparticles to receptors on biomembranes is critical to the development and screening of therapeutic materials. A prevailing understanding is that multivalent ligand-receptor binding leads to slower and confined translational motion of nanoparticles. In contrast, we report
Michael Estl et al.
International journal of molecular sciences, 21(7) (2020-04-08)
Cytotoxic T lymphocytes (CTL) are key players of the adaptive immune system that target tumors and infected cells. A central step to that is the formation of a cell-cell contact zone between the CTL and its target called an immune
Maria Tsemperouli et al.
Langmuir : the ACS journal of surfaces and colloids, 35(26), 8748-8757 (2019-06-28)
Horizontal black lipid membranes (BLMs) enable optical microscopy to be combined with the electrophysiological measurements for studying ion channels, peptide pores, and ionophores. However, a careful literature review reveals that simultaneous fluorescence and electrical recordings in horizontal BLMs have been
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique